ESTABLISHMENT LABS HOLDINGS INC
NASDAQ: ESTA (Establishment Labs Holdings Inc)
Last update: 2 days ago, 6:37PM56.57
-1.39 (-2.40%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bullish | Bearish |
| Medical Devices (Global) | Bullish | Bearish | |
| Stock | Establishment Labs Holdings Inc | Bullish | Bearish |
Analyst Consensus
4 Buy
Avg. Price @ Call: 49.33
|
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Cowen And Company, Llc | 31 Mar 2024 | 939,948 |
| Findell Capital Management Llc | 31 Mar 2024 | 785,020 |
| Rice Hall James & Associates, Llc | 31 Mar 2024 | 738,020 |
| Point72 Asset Management, L.P. | 31 Mar 2024 | 570,770 |
| 52 Weeks Range |
16.96 - 73.00
|
|
| Price Target Range | ||
| High | 65.00 (Mizuho, 14.90%) | Buy |
| Median | 60.00 (6.06%) | |
| Low | 53.00 (JP Morgan, -6.31%) | Buy |
| Average | 59.50 (5.18%) | |
| Total | 4 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 03 Apr 2024 | 60.00 (6.06%) | Buy | 52.79 |
| Mizuho | 01 Apr 2024 | 65.00 (14.90%) | Buy | 48.80 |
| TD Cowen | 12 Mar 2024 | 60.00 (6.06%) | Buy | 50.03 |
| JP Morgan | 29 Feb 2024 | 53.00 (-6.31%) | Buy | 45.68 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 08 May 2024 | Announcement | Establishment Labs Reports First Quarter 2024 Financial Results |
| 02 May 2024 | Announcement | Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024 |
| 01 May 2024 | Announcement | Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America |
| 24 Apr 2024 | Announcement | Establishment Labs to Announce First Quarter 2024 Financial Results on May 8 |
| 17 Apr 2024 | Announcement | Establishment Labs Announces Participation in The Aesthetic Meeting 2024 |
| 28 Feb 2024 | Announcement | Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance |
| 23 Feb 2024 | Announcement | Establishment Labs Announces Participation in Two Upcoming Investment Conferences |
| 22 Feb 2024 | Announcement | Establishment Labs Announces Amended Credit Facility with Oaktree |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |